AirXpanders Announces First Patient Treated in IDE Trial of New Post-Mastectomy Tissue Expansion Device

AirXpanders Announces First Patient Treated in IDE Trial of New Post-Mastectomy Tissue Expansion Device The XPAND trial will evaluate AeroForm™ as a possible alternative to standard tissue expansion in breast reconstruction process PALO ALTO, Calif. – December 5, 2011 – … Continue reading

AirXpanders Announces Publication of Data Supporting the Use of AeroForm™

Gallery

Peer-reviewed study published in Plastic and Reconstructive Surgery says device could “offer a new paradigm in breast reconstruction” PALO ALTO, Calif. (October, 2011) – AirXpanders Inc., a company developing technology to address current unmet needs for patients who require tissue … Continue reading

AirXpanders gets IDE to study AeroForm

Gallery

By AMANDA PEDERSENMedical Device Daily Senior Staff Writer There has to be a better way.That sentiment is what inspired the development of a new breast tissue expansion device for mastectomy patients undergoing breast reconstruction. The device, called AeroForm, was developed … Continue reading

FDA Grants AirXpanders an Investigational Device Exemption

Gallery

…to Begin Pivotal Study of an Investigational Tissue Expansion System for Women Undergoing Breast Reconstruction After Mastectomy Company to Launch Funding Round to Support AeroFormTM Through a Successful Commercial Launch PALO ALTO, CA–(Marketwire – Aug 29, 2011) – AirXpanders Inc., … Continue reading

Clinical Trials Available Online

Gallery

Please visit clinicaltrials.gov to see updated information about AirXpanders clinical trial (NCT01425268) in progress.  Once the clinicaltrials.gov site pulls up, please type AirXpanders into the search box and you will be connected to the XPAND trial information posted there.